Price
Target price
-
-
-
-
-
-
WKN: A3EDH2 / Symbol: TNXP / Name: Tonix Pharmaceuticals / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Tonix Pharmaceuticals Holding Corp. Stock
For the coming years our community has positive and negative things to say abot the Tonix Pharmaceuticals Holding Corp. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "EBIT growth" there were negative voices in the community.
Pros and Cons of Tonix Pharmaceuticals Holding Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
B****
?
S********** s********
Cons
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Tonix Pharmaceuticals Holding Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. | - | - | - | - | - | - | - |
| Sangamo Therapeutics Inc. | -29.780% | -28.034% | -47.326% | -77.235% | -53.545% | -89.092% | -98.322% |
| Evolus Inc | -0.440% | 13.182% | 16.719% | -56.059% | -17.761% | -42.168% | -41.792% |
| Corbus Pharmaceuticals Holding Inc. | -2.290% | 1.805% | 20.552% | 34.462% | 24.857% | 6696.267% | -79.570% |
Comments
Tonix Pharmaceuticals (TNXP) was downgraded by Wall Street Zen from "hold" to "sell".
Show more
Ratings data for TNXP provided by MarketBeat
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) had its "buy" rating re-affirmed by analysts at Alliance Global Partners.
Show more
Ratings data for TNXP provided by MarketBeat
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) had its "outperform" rating re-affirmed by analysts at Noble Financial. They now have a $70.00 price target on the stock.
Show more
Ratings data for TNXP provided by MarketBeat